Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-05

Clinical Trial Update: Safety and Efficacy of Inhaled Synthetic THC/CBD for Improving Physical Functioning and for Modulating Cachexia Progression in Patients With Advanced Cancer and Associated Cachexia [Phase 3]

View source ↗

Summary

Phase 3 trial assessing inhaled synthetic THC/CBD for improving physical functioning and modulating cachexia progression in patients with advanced cancer and ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • inhaled synthetic THC/CBD

Snippet

Sponsor: Tetra Bio-Pharma | Conditions: Cannabis Use, Cachexia; Cancer | Phase 3 | Status: SUSPENDED